Fabio
6.3 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, chapter_law, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | chapter_law | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Prescription Drugs | Prescription Drugs; Citing this act as the "Prescription Drug Reform Act"; specifying additional prohibited acts related to the Florida Drug and Cosmetic Act; requiring certain drug manufacturers to notify the Department of Business and Professional Regulation of reportable drug price increases on a specified form on the effective date of such increase; requiring the Division of Consumer Services of the Department of Financial Services to designate an employee as the primary contact for consumer complaints involving pharmacy benefit managers; providing a grandfathering provision for certain pharmacy benefit managers operating as administrators; requiring pharmacy benefits plans and programs, beginning on a specified date, to annually submit a certain attestation to the Office of Insurance Regulation, etc. | us/states/fl | Florida Legislature | 2023 | SB 1550 | Florida SB 1550 (2023) |
|
|
enacted | 2023-29 |
|
6 | 38 | 5 | 2023-03-03 | 2023-05-04 | openstates | ocd-bill/bd904415-ae13-47c2-8b85-29e69f9ee03a | https://flsenate.gov/Session/Bill/2023/1550/ByCategory | d01340a8348bece6a6a91fa4097ee20533051c45f17db62a194263a1f550c9f8 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Florida SB 1550 (2023) — Prescription Drugs
Prescription Drugs; Citing this act as the "Prescription Drug Reform Act"; specifying additional prohibited acts related to the Florida Drug and Cosmetic Act; requiring certain drug manufacturers to notify the Department of Business and Professional Regulation of reportable drug price increases on a specified form on the effective date of such increase; requiring the Division of Consumer Services of the Department of Financial Services to designate an employee as the primary contact for consumer complaints involving pharmacy benefit managers; providing a grandfathering provision for certain pharmacy benefit managers operating as administrators; requiring pharmacy benefits plans and programs, beginning on a specified date, to annually submit a certain attestation to the Office of Insurance Regulation, etc.
Enacted — Laws of Florida, Chapter 2023-29.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- S 1550 Filed (filed) — source
- S 1550 c1 (committee substitute) — source
- S 1550 c2 (committee substitute) — source
- S 1550 e1 (engrossed) — source
- S 1550 e2 (engrossed) — source
- S 1550 er (enrolled) — source
Votes
- Returning Messages — 40–0 (pass) · upper
- Third Reading — 40–0 (pass) · upper
- Favorable with Committee Substitute — 12–0 (pass) · upper
- Favorable with Committee Substitute — 18–1 (pass) · upper
- Passage, Third Reading — 118–0 (pass) · lower
Sponsors
- Brodeur — primary (person)
- Fiscal Policy — primary (person)
- Health Policy — primary (person)
- Perry — cosponsor (person)
- Rodriguez — cosponsor (person)
- Wright — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2023-03-03 Filed
filing - 2023-03-09 Referred to Health Policy; Fiscal Policy
referral-committee - 2023-03-14 Introduced
introduction - 2023-03-22 On Committee agenda-- Health Policy, 03/27/23, 3:00 pm, 412 Knott Building
- 2023-03-27 CS by Health Policy; YEAS 12 NAYS 0
- 2023-03-29 Pending reference review under Rule 4.7(2) - (Committee Substitute)
- 2023-03-29 Now in Fiscal Policy
- 2023-03-29 CS by Health Policy read 1st time
- 2023-04-10 On Committee agenda-- Fiscal Policy, 04/13/23, 10:30 am, 412 Knott Building
- 2023-04-13 CS/CS by- Fiscal Policy; YEAS 18 NAYS 1
- 2023-04-14 Pending reference review -under Rule 4.7(2) - (Committee Substitute)
- 2023-04-14 Placed on Calendar, on 2nd reading
- 2023-04-14 Placed on Special Order Calendar, 04/18/23
- 2023-04-17 CS/CS by Fiscal Policy read 1st time
- 2023-04-18 Read 2nd time
reading-2 - 2023-04-18 Amendment(s) adopted (392522, 438956, 633284, 704080)
- 2023-04-18 Ordered engrossed
- 2023-04-18 Placed on 3rd reading
reading-3 - 2023-04-19 Read 3rd time
reading-3 - 2023-04-19 CS passed as amended; YEAS 40 NAYS 0
passage - 2023-04-19 Immediately certified
- 2023-04-19 In Messages
- 2023-04-28 Bill referred to House Calendar
- 2023-04-28 Bill added to Special Order Calendar (5/1/2023)
- 2023-04-28 1st Reading (Engrossed 1)
reading-1 - 2023-05-01 Read 2nd time
reading-2 - 2023-05-01 Amendment 207723 adopted
- 2023-05-01 Placed on 3rd reading
reading-3 - 2023-05-01 Added to Third Reading Calendar
- 2023-05-02 Read 3rd time
reading-3 - 2023-05-02 CS passed as amended; YEAS 118, NAYS 0
passage - 2023-05-02 In returning messages
- 2023-05-02 Concurred in 1 amendment(s) (207723)
- 2023-05-02 CS passed as amended; YEAS 40 NAYS 0
passage - 2023-05-02 Ordered engrossed, then enrolled
enrolled - 2023-05-03 Signed by Officers and presented to Governor
executive-receipt - 2023-05-03 Approved by Governor
executive-signature - 2023-05-04 Chapter No. 2023-29, companion bill(s) passed, see CS/SB 1552 (Ch. 2023-30)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/bd904415-ae13-47c2-8b85-29e69f9ee03a. Confidence: reported (aggregated from official Florida legislature records).